Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2026-03-04 @ 11:10 PM
Study NCT ID:
NCT00321620
Status:
COMPLETED
Last Update Posted:
2018-08-29
First Post:
2006-05-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20050103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None